A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.

Over the years, the biomaterials company has collaborated with the likes of Sydney-born brand Lee Mathews, Waverly Mills in Tasmania, and allowed a Western Australian fashion student to test its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Precision BioSciences is ...

Knoll Capital Management added 473,591 shares of Nuvation Bio in the fourth quarter; the estimated trade size was $2.93 million. Meanwhile, the quarter-end position value increased by $7.88 million, ...

Monday, March 16 th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of ...

A robot at work inside CMU's Biological and Chemical Innovation Cloud Lab. GIF: Ryan Deto/Axios Pittsburgh's biotech industry is ahead of the curve, according to the National Security Commission on ...

China's ongoing "artificial intelligence plus" strategy is also significantly accelerating biomanufacturing, especially in ...

London biotech startup Ternary Therapeutics has raised £3.6m to scale its AI-powered platform designed to engineer molecular ...

By mining massive biological datasets, AI has been used in biotechnology for drug discovery for more than a decade, although ...

According to new analysis by Future Market Insights, the global personal care and cosmetics microalgae market is emerging as ...

Deep Origin, the computational drug discovery company replacing guesswork with prediction in small molecule drug development, today announced the promotion of Natalie Ma, PhD, to Chief Business ...

Management anticipates initiating dose expansion cohorts for VIR-5500 in the second quarter of 2026 and advancing into Phase III development in 2027. The company expects its cash runway, including ...